1-20. (canceled)
21. A method of radioiodination of a biological targeting moiety, said method comprising:
(i) provision of a compound of Formula (I):
(ii) reaction of said compound of Formula (I) with a compound of Formula (IIa) or Formula (IIb):
I*\u2014Y1-N3 \u2003\u2003(IIa)
I*\u2014Y1\u2014CH\u2261N+\u2014O\u2212\u2003\u2003(IIb)
in the presence of a click cycloaddition catalyst, to give a conjugate of Formula (IIIa) or (IIIb) respectively:
wherein:
I* is a radioisotope of iodine suitable for in vivo imaging, chosen from 123I, 124I or 131I;
L1 is a linker group which may be present or absent, wherein said linker group is of formula -(A)m- wherein each A is independently \u2014CR2\u2014, \u2014CR\u2550CR\u2014, \u2014C\u2261C\u2014, \u2014CR2CO2\u2014, \u2014CO2CR2\u2014, \u2014NRCO\u2014, \u2014CONR\u2014, \u2014NR(C\u2550O)NR\u2014, \u2014NR(C\u2550S)NR\u2014, \u2014SO2NR\u2014, \u2014NRSO2\u2014, \u2014CR2OCR2\u2014, \u2014CR2SCR2\u2014, \u2014CR2NRCR2\u2014, a C4-8 cycloheteroalkylene group, a C4-8 cycloalkylene group, a C5-12 arylene group, or a C3-12 heteroarylene group, an amino acid, a sugar or a monodisperse polyethyleneglycol (PEG) building block;
wherein each R is independently chosen from: H, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxyalkyl or C1-4 hydroxyalkyl;
and m is an integer of value 1 to 20;
Y1 is \u2014Ar1\u2014 or \u2014X1\u2014;
where \u2014Ar1\u2014 is C3-10 arylene, and
\u2014X1\u2014 is \u2014CH\u2550CH\u2014(CH2)n\u2014(Ar1)j\u2014 or \u2014CH\u2550CH\u2014(Ar1)j\u2014(CH2)n\u2014
where j is 0 or 1, and n is an integer of value 0 to 4,
wherein when Y1 is \u2014X1\u2014, I* is attached to \u2014CH\u2550CH terminus of X1;
BTM is the biological targeting moiety chosen from: a single amino acid, a 3-80 mer peptide, an enzyme substrate, an enzyme antagonist an enzyme agonist, an enzyme inhibitor or a receptor-binding compound.
22. The method according to claim 21, where I* is 123I.
23. The method according to claim 21 wherein BTM is an RGD peptide.
24. The method according to claim 21, wherein BTM is a peptide comprising the fragment:
25. The method according to claim 21 where BTM is a peptide of formula (A):
wherein X1 is either \u2014NH2 or
wherein a is an integer of from 1 to 10.
26. The method according to claim 21, wherein the click cycloaddition catalyst is a Cu(I) catalyst which comprises elemental copper.
27. The method according to claim 26, wherein the elemental copper comprises:
(i) copper powder with a particle size in the range from 0.001 to 1 mm;
(ii) copper wire with a diameter in the range of 0.01 to 1.0 mm.
28. A compound of Formula (IIIa) or (IIIb):
where: L1, Y1, I* is and BTM are as defined in claim 21.
29. A compound of Formula (IIaa) or (IIbb), useful in the method of claim 21:
I*\u2014Y1\u2014N3 \u2003\u2003(IIaa)
I*\u2014Y1\u2014CH\u2261N+\u2014O\u2212\u2003\u2003(IIbb)
where I* and Y1 are as defined in claim 21.
30. A radiopharmaceutical composition comprising an effective amount of a compound of Formula (IIIa) or (IIIb) according to claim 28, together with a biocompatible carrier medium.
31. Use of a compound according to claim 28 for the manufacture of a radiopharmaceutical for use in a method of in vivo imaging or in vivo radiotherapy.
32. Use of an automated synthesizer apparatus to carry out the method of claim 21.
33. A single use, sterile cassette suitable for use in the automated synthesizer method of claim 21, said cassette comprising the non-radioactive reagents necessary to carry out the method in sterile, apyrogenic form.
34. A method of generating an image of a human or animal body comprising administering a compound according to claim 28, and generating an image of at least a part of said body to which said compound or composition has distributed using PET or SPECT.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
We claim:
1. A method for preparing a polyurea polymer formulation comprising:
admixing a polyisocyanate, an isocyanate-reactive material, and a fatty-acid ester to form a mixture, said fatty-acid ester being present in an amount effective for providing blister resistance to a molded polyurea polymer prepared from said mixture such that when said molded polyurea polymer is exposed to moisture and a temperature of at least 350 F. (177 C.), said molded polyurea polymer is substantially free of blisters.
2. The method of claim 1, wherein said isocyanate-reactive material is at least one of a polyamine and a polyol.
3. The method of claim 1, wherein a polyepoxide is admixed with said mixture.
4. The method of claim 1, wherein said mixture has an isocyanate index of between 1.05 and 1.40.
5. The method of claim 1, wherein said mixture has an isocyanate index of 1.20.
6. The method of claim 3, wherein said mixture has an isocyanate index of 1.05.
7. The method of claim 1 , wherein the fatty-acid ester is jojoba oil.
8. The method of claim 1, wherein said fatty-acid ester is present in an amount of at least 0.5 weight percent based on the weight of said mixture excluding the weight of said polyisocyanate.
9. The method of claim 1, wherein said fatty-acid ester is present in an amount of at least 1.5 weight percent based on the weight of said mixture excluding the weight of said polyisocyanate.
10. The method of claim 1, wherein said molded polyurea polymer is exposed to a temperature of at least 375 F. (190 C.).
11. The method of claim 1, wherein said molded polyurea polymer is exposed to a temperature of at least 390 F. (199 C.).
12. The method of claim 1, wherein said molded polyurea polymer is exposed to a temperature of at least 400 F. (204 C.).
13. The method of claim 1, wherein when said molded polyurea polymer is exposed to moisture, said molded polyurea polymer takes up no more than 2 weight-percent water based on the weight of said molded polyurea polymer.
14. The method of claim 1, wherein said molded polyurea polymer is exposed to said temperature for at least 20 minutes and no longer than 60 minutes.
15. The method of claim 1, wherein said molded polyurea polymer is molded by reaction injection molding.
16. The method of claim 1, wherein said molded polyurea polymer is suitable for use in an e-coat process.
17. A method of improving a molded polyurea polymer’s blister resistance, said method comprising:
(A) adding an effective amount of a fatty-acid ester to a polyurea-polymer formulation comprising a polyisocyanate and an isocyanate-reactive material to prepare a mixture; and
(B) molding said mixture to prepare a molded polyurea polymer,
wherein said molded mixture develops substantially fewer blisters, as compared to a molded mixture that is substantially free of a fatty-acid ester, when exposed to moisture and a temperature of at least 350 F. (177 C.), said molded polyurea polymer being exposed to said temperature for at least 20 minutes and no longer than 60 minutes.
18. The method of claim 17, wherein said mixture has an isocyanate index between 1.05 and 1.40.
19. The method of claim 17, wherein said mixture further comprises a polyepoxide.
20. The method of claim 17, wherein said fatty-acid ester is jojoba oil.
21. The method of claim 17, wherein said isocyanate-reactive material is at least one of a polyamine and a polyol.
22. The method of claim 17, wherein said fatty-acid ester is present in an amount of at least 0.5 weight percent based on the weight of said mixture excluding the weight of said polyisocyanate.
23. The method of claim 17, wherein said molded polyurea polymer is exposed to a temperature of at least 375 F. (190 C.).
24. The method of claim 17, wherein when said molded polyurea polymer is exposed to moisture, said molded polyurea polymer takes up no more than 2 weight-percent water based on the weight of said molded polyurea polymer.
25. The method of claim 17, wherein said mixture is molded by reaction injection molding.
26. A polyurea-polymer formulation prepared by a method comprising:
admixing a polyisocyanate, an isocyanate-reactive material, and a fatty-acid ester to form a mixture, said fatty-acid ester being present in an amount effective for providing blister resistance to a molded polyurea polymer prepared from said mixture such that when said molded polyurea polymer is exposed to moisture and a temperature of at least 350 F. (177 C.), said molded polyurea polymer is substantially free of blisters.
27. A molded polyurea polymer prepared by a method comprising:
(A) admixing a polyisocyanate, an isocyanate-reactive material, and a fatty-acid ester to form a mixture; and
(B) molding said mixture using reaction injection molding to form a molded polyurea polymer,
wherein said mixture contains said fatty-acid ester in an amount effective for providing blister resistance to said molded polyurea polymer such that when said molded polyurea polymer is exposed to moisture and a temperature of at least 350 F. (177 C.), said molded polyurea polymer is substantially free of blisters.
28. A polyurea-polymer formulation suitable for preparing a molded polyurea polymer, said formulation comprising: a polyisocyanate, an isocyanate-reactive material, and a fatty-acid ester, said fatty-acid ester being present in an amount effective for providing blister resistance to a molded polyurea polymer prepared from said formulation such that when said molded polyurea polymer is exposed to moisture and a temperature of at least 350 F. (177 C), said molded polyurea polymer is substantially free of blisters.
29. The formulation of claim 28, wherein said isocyanate-reactive material is at least one of a polyamine and a polyol.
30. The formulation of claim 28, wherein said fatty-acid ester is jojoba oil.
31. The formulation of claim 28 further comprising at least one additive, said additive being at least one of a chain extender, a catalyst, a surfactant, and an internal-mold-release agent.
32. The formulation of claim 28 further comprising a polyepoxide.